Attorney Alan Arville provides strategic, transactional, and regulatory guidance to the health care industry.
His practice focuses on matters relating to the distribution, dispensing, and reimbursement of pharmaceuticals, including Medicare Part D, Medicare Advantage, the 340B Drug Discount Program, federal anti-kickback and anti-inducement laws, HIPAA privacy and security, health care licensing, drug purchase agreements, payor contracting, and affiliations and other collaborative arrangements. Alan’s clients include regional and national pharmacy chains; specialty pharmacies; health care systems; disproportionate share hospitals, federal grantees, and other 340B-covered entities; drug manufacturers and distributors; group purchasing organizations; and pharmacy services administrative organizations. Alan also devotes a substantial portion of his practice to representing private equity firms in the evaluation, due diligence, and acquisition of health care companies.
Pharmacies (chain and independent pharmacies, retailers with pharmacy operations, and specialty pharmacies) seek Alan’s advice on a diverse array of transactions and compliance issues. For example, Alan advises on patient reward and drug discount programs, manufacturer and third-party payor relations, Medicare Part D compliance, medication therapy management services, health and wellness programs, data sharing arrangements, 340B contract pharmacy arrangements, and limited distribution network and other specialty pharmacy models.
Alan also has extensive experience working with disproportionate share hospitals, federal grantees, and other 340B covered entities, contract pharmacies, and 340B management service providers on 340B compliance, outlook, and strategy. Covered entities turn to Alan for assistance with implementing 340B compliance policies and procedures, contract pharmacy arrangements, self-assessments, and independent audits. He also helps covered entities with HRSA audits, manufacturer audits, and self-disclosures.
Alan is an editor of and contributor to the firm’s Health Law Advisor blog, the editor of Epstein Becker Green’s Antitrust Byte client alerts, the author of numerous articles, and a frequent speaker on health care topics. He is a current member of the Board of Trustees of the Academy of Managed Care Pharmacy Foundation (AMCP Foundation).
- Represented a national digital pharmacy in its sale to a multinational e-commerce and technology company. Alan served as lead health regulatory counsel in negotiating the terms of the purchase agreement, navigating regulatory approvals for the change of ownership, and responding to the buyer’s health regulatory due diligence.
- Advised a national delivery service company on its expansion to pharmacy and telemedicine, including the structure, licensing, and regulatory compliance of new pharmacy and telemedicine business lines.
- Advised a ride-sharing technology company on the U.S. Food and Drug Administration (FDA), board or pharmacy, and privacy requirements applicable to home delivery of COVID-19 tests and prescription drugs.
- Served as lead counsel on the creation, structure, and compliant operations of a new pharmacy services administrative organization to contract with health plans and pharmacy benefit managers on behalf of regional pharmacies.
- Negotiated the terms of, and drafted contracts to implement, numerous 340B contract pharmacy arrangements among hospitals, retail pharmacy chains, and 340B technology services vendors.
- Represented a national pharmacy network in its sale to a specialty health care management company. As health regulatory counsel, Alan responded to the buyer’s due diligence inquiries, conducted health regulatory due diligence of the buyer, negotiated health regulatory-related aspects of the merger agreement and other transactional documents, and coordinated federal and state health regulatory filings.
- Chambers USA: The World's Leading Lawyers for Business, "Up and Coming" in District of Columbia—Healthcare (2022-2023)
- The Best Lawyers in America©, Health Care Law (2022-2024)
- Washington DC Rising Stars, Health Care (2013)
- Nightingale's Healthcare News, One of the "Outstanding Young Healthcare Lawyers for 2008"
- Georgetown University Law Center (J.D., cum laude, 2003)
- University of Dayton (B.A., 2000)
- District of Columbia
- U.S. Court of Appeals for the District of Columbia Circuit
Professional & Community Involvement
- Academy of Managed Care Pharmacy Foundation (AMCP Foundation), Board of Trustees
- American Bar Association
- American Health Lawyers Association, Hospitals and Health Systems Practice Group
- District of Columbia Bar Association, Health Law Section Steering Committee, 2012-2015; Programs Committee, Chair; Nominating Committee, Chair
- August 2, 2022
- June 7, 2022